Search - tctmd.com

Displaying 541 - 560 of 701

Sort: Relevancy | Date

News Daily News

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

L.A. McKeown

October 03, 2014

News Daily News

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

L.A. McKeown

October 03, 2014

Presentation TCT 2014

Apixaban in ACS and Atrial Fibrillation: Comparison to Warfarin and Aspirin

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Christopher B. Granger

September 15, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Daily News

Proximal May Be Preferred Form of Embolic Protection in Carotid Stenting

August 07, 2014

News Daily News

La Protección Embólica Proximal podría ser la Fórmula Preferida en la Implantación de Stents Carotídeos

August 07, 2014

News Daily News

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Yael L. Maxwell

June 27, 2014

News Daily News

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

Yael L. Maxwell

June 27, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Daily News

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

May 05, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

L.A. McKeown

April 22, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

News Conference News ACC 2014

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Caitlin E. Cox

April 02, 2014

News Daily News

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Caitlin E. Cox

March 27, 2014

News Daily News

Los Pacientes Ancianos con SCA Reciben Menos Tratamiento Intensivo siendo Menores los Beneficios sobre la Supervivencia

Caitlin E. Cox

March 27, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Daily News

Beneficio sobre la Mortalidad con Inhibidores de la ECA en la EAC No Obstructiva

L.A. McKeown

March 20, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

Advertisement

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

Apixaban in ACS and Atrial Fibrillation: Comparison to Warfarin and Aspirin

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Proximal May Be Preferred Form of Embolic Protection in Carotid Stenting

La Protección Embólica Proximal podría ser la Fórmula Preferida en la Implantación de Stents Carotídeos

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Los Pacientes Ancianos con SCA Reciben Menos Tratamiento Intensivo siendo Menores los Beneficios sobre la Supervivencia

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

Beneficio sobre la Mortalidad con Inhibidores de la ECA en la EAC No Obstructiva

Apixaban es Rentable comparado con Warfarina o Aspirina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content